Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 12, 2026, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Tretinoin Cream USP, 0.05%.".
Alembic Pharmaceuticals Limited Press Release Jun 12 2026
Earlier from Alembic Pharmaceuticals
- Alembic Pharmaceuticals Limited Press Release Jun 11 2026
- Press Release Jun 05 2026
- Press Release May 22 2026
- Press Release May 15 2026